PubRank

J E Bennett

Author PubWeight™ 281.10‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2001 12.73
2 A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute. N Engl J Med 1994 9.11
3 Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiol 1982 6.78
4 Prognostic factors in cryptococcal meningitis. A study in 111 cases. Ann Intern Med 1974 6.75
5 Aspergillosis. The spectrum of the disease in 98 patients. Medicine (Baltimore) 1970 5.98
6 A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis. N Engl J Med 1979 5.87
7 Variables influencing susceptibility testing of Cryptococcus neoformans to 5-fluorocytosine. Antimicrob Agents Chemother 1973 5.84
8 Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol 1984 5.74
9 A pharmacologic guide to the clinical use of amphotericin B. J Infect Dis 1969 5.58
10 Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B. J Clin Microbiol 1986 5.19
11 Serologic grouping of Cryptococcus neoformans. Proc Soc Exp Biol Med 1968 4.97
12 Taxonomic studies on Filobasidiella species and their anamorphs. Antonie Van Leeuwenhoek 1982 4.90
13 Correlation of in vitro susceptibility test results with in vivo response: flucytosine therapy in a systemic candidiasis model. J Infect Dis 1983 4.42
14 Chronic mucocutaneous candidiasis: model-building in cellular immunity. Ann Intern Med 1971 4.41
15 Chemotherapy of systemic mycoses (first of two parts). N Engl J Med 1974 4.20
16 Epidemiologic differences among serotypes of Cryptococcus neoformans. Am J Epidemiol 1977 3.91
17 Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 Candida albicans isolates from the United States. Antimicrob Agents Chemother 1982 3.91
18 Effect of the laccase gene CNLAC1, on virulence of Cryptococcus neoformans. J Exp Med 1996 3.76
19 Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro. J Infect Dis 1972 3.75
20 Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America. Clin Infect Dis 2000 3.70
21 Distribution of alpha and alpha mating types of Cryptococcus neoformans among natural and clinical isolates. Am J Epidemiol 1978 3.55
22 Control for rheumatoid factor in the latex test for cryptococcosis. Am J Clin Pathol 1971 3.47
23 The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection. J Immunol 1974 3.38
24 Capsular polysaccharides of Cryptococcus neoformans. Rev Infect Dis 1984 3.10
25 Amphotericin B pharmacokinetics in humans. Antimicrob Agents Chemother 1978 2.79
26 Disseminated cryptococcosis in man: decreased lymphocyte transformation in response to Cryptococcus neoformans. J Infect Dis 1973 2.45
27 Growth of Cryptococcus neoformans within human macrophages in vitro. Infect Immun 1973 2.39
28 Deletion of the Candida glabrata ERG3 and ERG11 genes: effect on cell viability, cell growth, sterol composition, and antifungal susceptibility. Antimicrob Agents Chemother 1995 2.32
29 Fungemia with compromised host resistance. A study of 70 cases. Ann Intern Med 1974 2.25
30 Galactomannan antigenemia and antigenuria in aspergillosis: studies in patients and experimentally infected rabbits. J Infect Dis 1987 2.18
31 Pharmacological studies with 5-fluorocytosine. Antimicrob Agents Chemother 1972 2.14
32 Detection of Candida antigen in sera of patients with candidiasis by an enzyme-linked immunosorbent assay-inhibition technique. J Clin Microbiol 1979 2.13
33 Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group. Clin Infect Dis 1995 2.11
34 Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity. Infect Immun 1991 2.11
35 New, special stain for histopathological diagnosis of cryptococcosis. J Clin Microbiol 1981 2.04
36 5-fluorocytosine resistance in Cryptococcus neoformans. Antimicrob Agents Chemother 1973 2.00
37 Clotrimazole: new drug for systemic mycoses? Ann Intern Med 1970 1.99
38 Abnormalities in cell-mediated immunity in patients with Cryptococcus neoformans infection. J Allergy Clin Immunol 1975 1.99
39 Invasive aspergillosis. Absence of detectable antibody response. Am Rev Respir Dis 1971 1.96
40 Concentrations of airborne Aspergillus compared to the incidence of invasive aspergillosis: lack of correlation. Med Mycol 1998 1.83
41 Biochemical differences between serotypes of Cryptococcus neoformans. Sabouraudia 1978 1.83
42 Complement depletion in cryptococcal sepsis. J Immunol 1978 1.82
43 Serology of human cryptococcosis. Ann Intern Med 1968 1.78
44 Fluconazole resistance associated with drug efflux and increased transcription of a drug transporter gene, PDH1, in Candida glabrata. Antimicrob Agents Chemother 1998 1.76
45 Chemotherapy of systemic mycoses (second of two parts). N Engl J Med 1974 1.73
46 Standardization of a fluconazole bioassay and correlation of results with those obtained by high-pressure liquid chromatography. Antimicrob Agents Chemother 1991 1.72
47 Selection of ura5 and ura3 mutants from the two varieties of Cryptococcus neoformans on 5-fluoroorotic acid medium. J Med Vet Mycol 1992 1.71
48 High prevalence of Cryptococcus neoformans var. gattii in tropical and subtropical regions. Zentralbl Bakteriol Mikrobiol Hyg A 1984 1.68
49 Flucytosine and amphotericin B: hemodialysis effects on the plasma concentration and clearance. Studies in man. Ann Intern Med 1974 1.63
50 Experience with a new skin test antigen prepared from Cryptococcus neoformans. Am Rev Respir Dis 1968 1.62
51 Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia. N Engl J Med 1973 1.61
52 Diagnosis of systemic candidiasis by latex agglutination for serum antigen. J Clin Microbiol 1985 1.56
53 Normal and deficient neutrophils can cooperate to damage Aspergillus fumigatus hyphae. J Infect Dis 1990 1.55
54 Long-lasting, specific immunologic unresponsiveness associated with cryptococcal meningitis. J Clin Invest 1982 1.53
55 Diversity of DNA fingerprints in Cryptococcus neoformans. J Clin Microbiol 1995 1.50
56 Catastrophic visual loss due to Cryptococcus neoformans meningitis. Medicine (Baltimore) 1993 1.50
57 The combined effect of 5-fluorocytosine and amphotericin B in the therapy of murine cryptococcosis. Proc Soc Exp Biol Med 1973 1.49
58 Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses. Clin Infect Dis 2001 1.48
59 Rapid diagnosis of candidiasis and aspergillosis. Rev Infect Dis 1987 1.41
60 Mode of action of 5-fluorocytosine. Biochem Pharmacol 1978 1.40
61 Flucytosine interference in creatinine assay. J Infect Dis 1990 1.39
62 The passion and action of our time and surgical excellence. Am J Surg 1974 1.39
63 Evidence for conversion of 5-fluorocytosine to 5-fluorouracil in humans: possible factor in 5-fluorocytosine clinical toxicity. Antimicrob Agents Chemother 1978 1.38
64 The role of late complement components and the alternate complement pathway in experimental cryptococcosis. Proc Soc Exp Biol Med 1973 1.38
65 Receptor-mediated clearance of Aspergillus galactomannan. J Infect Dis 1987 1.35
66 Breast volume and anthropomorphic measurements: normal values. Plast Reconstr Surg 1986 1.31
67 Searching for the yeast connection. N Engl J Med 1990 1.29
68 Cloning and characterization of a Candida albicans maltase gene involved in sucrose utilization. J Bacteriol 1992 1.29
69 Oxidative killing of Aspergillus fumigatus proceeds by parallel myeloperoxidase-dependent and -independent pathways. Infect Immun 1987 1.26
70 Outbreak of human parainfluenza virus 3 infections in a hematopoietic stem cell transplant population. J Infect Dis 2001 1.26
71 Chronic meningitis. Medicine (Baltimore) 1976 1.25
72 Aspergillus infections in cancer patients. Association with fireproofing materials in a new hospital. JAMA 1976 1.25
73 Galactofuranosyl groups are immunodominant in Aspergillus fumigatus galactomannan. Mol Immunol 1985 1.23
74 Lectin-like attachment sites on murine pulmonary alveolar macrophages bind Aspergillus fumigatus conidia. J Infect Dis 1988 1.22
75 Comparative safety, tolerance, and pharmacokinetics of amphotericin B lipid complex and amphotericin B desoxycholate in healthy male volunteers. J Infect Dis 1991 1.18
76 Cloning, sequencing, expression and allelic sequence diversity of ERG3 (C-5 sterol desaturase gene) in Candida albicans. Gene 1999 1.16
77 Efficacies of four antifungal agents in experimental murine sporotrichosis. Antimicrob Agents Chemother 1988 1.16
78 Variant forms of pulmonary cryptococcosis. Ann Intern Med 1968 1.15
79 A subcutaneous reservoir for intrathecal therapy of fungal meningitis. N Engl J Med 1973 1.13
80 In vivo interferon-gamma therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae. J Infect Dis 1991 1.13
81 Chronic meningitis caused by Cladosporium trichoides. Am J Clin Pathol 1973 1.12
82 Expanding forearm hematoma after apparent minor injury. Plast Reconstr Surg 1965 1.12
83 Chronic fungal sinusitis in apparently normal hosts. Medicine (Baltimore) 1988 1.12
84 Stability of amphotericin B in infusion bottles. Antimicrob Agents Chemother 1973 1.11
85 Genetic analysis of azole resistance in the Darlington strain of Candida albicans. Antimicrob Agents Chemother 2000 1.09
86 Clinical features of extracutaneous sporotrichosis. Medicine (Baltimore) 1967 1.08
87 Differences in Cryptococcus neoformans capsular polysaccharide structure influence assembly of alternative complement pathway C3 convertase on fungal surfaces. Mol Immunol 1991 1.06
88 Inhibition of complement by culture supernatants of Aspergillus fumigatus. J Infect Dis 1986 1.05
89 Beta 1,4-oligoglucosides inhibit the binding of Aspergillus fumigatus conidia to human monocytes. J Infect Dis 1991 1.05
90 Phagocytic and fungicidal activity of monocytes from patients with acquired immunodeficiency syndrome. J Infect Dis 1985 1.04
91 Treatment of hydrocephalus secondary to cryptococcal meningitis by use of shunting. Clin Infect Dis 1999 1.02
92 Esophageal cryptococcosis in a patient with the hyperimmunoglobulin E-recurrent infection (Job's) syndrome. Gastroenterology 1984 1.00
93 Identification of Cryptococcus neoformans in a routine clinical laboratory. Mycopathol Mycol Appl 1968 1.00
94 Giant hairy nevus: preventable cause of amblyopia. J Pediatr Ophthalmol 1977 0.99
95 Tolerance to cryptococcal polysaccharide in cured cryptococcosis patients: failure of antibody secretion in vitro. Clin Exp Immunol 1986 0.97
96 Miconazole in cryptococcosis and systemic candidiasis: a word of caution. Ann Intern Med 1981 0.97
97 Urease inhibition by EDTA in the two varieties of Cryptococcus neoformans. Infect Immun 1987 0.96
98 Enhanced oxidative killing of azole-resistant Candida glabrata strains with ERG11 deletion. Antimicrob Agents Chemother 1996 0.94
99 Cryptococcal skin test antigen: preparation variables and characterization. Infect Immun 1981 0.94
100 Flucytosine monotherapy for cryptococcosis. Clin Infect Dis 1998 0.93
101 Susceptibility of Cryptococcus neoformans to amphotericin B. Antimicrob Agents Chemother (Bethesda) 1966 0.93
102 Purification, reconstitution, and inhibition of cytochrome P-450 sterol delta22-desaturase from the pathogenic fungus Candida glabrata. Antimicrob Agents Chemother 1999 0.93
103 Group B streptococcal necrotizing fasciitis arising from an episiotomy. Obstet Gynecol 1985 0.92
104 Persistence of cryptococcomas on neuroimaging. Clin Infect Dis 2000 0.90
105 Experimental therapy of cladosporiosis and sporotrichosis with 5-fluorocytosine. Antimicrob Agents Chemother 1973 0.90
106 Assessment of immunochemical methods for determining low concentrations of albumin in urine. Clin Chem 1986 0.89
107 Criteria for evaluation of therapeutic response to antifungal drugs. Rev Infect Dis 1981 0.88
108 Bioassay for SF 86-327, a new antifungal agent. Antimicrob Agents Chemother 1986 0.88
109 Glossopalatine ankylosis. Plast Reconstr Surg 1968 0.88
110 Minimal deviation melanoma with epidermotropic metastases arising in a congenital nevus. Am J Surg Pathol 1980 0.86
111 Auricular compression stent. J Prosthet Dent 1985 0.86
112 Scleroderma en coup de sabre. Ann Plast Surg 1983 0.85
113 Anticryptococcal type D antibodies raised in rabbits. Mol Immunol 1983 0.85
114 Further experience with the alcohol test for cryptococcal meningitis. Am J Med Sci 1966 0.85
115 The selective use of systemic antibiotics in the treatment of burns. Surg Gynecol Obstet 1980 0.84
116 Potential for laboratory exposures to biohazardous agents found in blood. Am J Public Health 1990 0.84
117 Role of maltase in the utilization of sucrose by Candida albicans. Biochem J 1993 0.83
118 An enzymatic method for 5-fluorocytosine. Clin Chem 1988 0.83
119 Diagnosis and management of candidiasis in the immunosuppressed host. Scand J Infect Dis Suppl 1978 0.83
120 Recruiting. Surgery 1983 0.82
121 Decompression in constricting burns: a reappraisal. Surgery 1966 0.82
122 Hair implant complications. JAMA 1981 0.82
123 Treatment of arteriovenous fistulas in cavernous hemangiomas of face by muscle embolization. Case report. Plast Reconstr Surg 1972 0.82
124 Effect of chronic anemia on the tensile strength of healing wounds. Surgery 1969 0.82
125 Organisms mimicking Pneumocystis carinii. Lancet 1976 0.82
126 Acquisition of vascular supply by cutaneous flaps in pigs. Surg Forum 1976 0.81
127 Administration of potassium iodide to normal volunteers does not increase killing of Sporothrix schenckii by their neutrophils or monocytes. J Med Vet Mycol 1990 0.80
128 Immune-globulin prophylaxis of respiratory syncytial virus infection in patients undergoing stem-cell transplantation. J Infect Dis 2002 0.80
129 Deep Candida infections in the neutropenic and non-neutropenic host: an ISHAM symposium. Med Mycol 2000 0.80
130 Surgical treatment of congenital breast asymmetry. Ann Plast Surg 1986 0.80
131 Nasal obstruction as a complication of pharyngeal flap surgery. Cleft Palate J 1980 0.80
132 Chemosurgical reports. Dermatofibrosarcoma protuberans of the face. J Dermatol Surg Oncol 1982 0.80
133 Factors influencing susceptibility of Nocardia species to trimethoprim-sulfamethoxazole. Antimicrob Agents Chemother 1978 0.79
134 Evolution of the electro-dermatome. Plast Reconstr Surg 1970 0.79
135 Active Histoplasma meningitis of 22 years' duration. JAMA 1975 0.79
136 The spreading enzymes and localized edema: a study of wringer crush injury in the rabbit. J Trauma 1970 0.79
137 Erythropoietin concentration in amphotericin B-induced anemia. Antimicrob Agents Chemother 1978 0.78
138 Dental health and viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2001 0.78
139 Small subunit ribosomal RNA of Blastomyces dermatitidis: sequence and phylogenetic analysis. J Gen Microbiol 1992 0.78
140 The voice of polite dissent--burned hands. Plast Reconstr Surg 1975 0.78
141 An incident of familial cancer, including 3 cases of osteogenic sarcoma. Cancer 1970 0.77
142 Bimanual co-ordination in Huntington's disease. Exp Brain Res 2000 0.77
143 Treatment of carcinoma of the prostate by cobalt-beam therapy. Radiology 1968 0.77
144 A ganglion of the temporomandibular joint presenting as a parotid tumor. Head Neck Surg 1981 0.77
145 Cutaneous postirradiation sarcoma. Ultrastructural evidence of pluripotential mesenchymal cell derivation. Cancer 1985 0.77
146 Syndactyly with ipsilateral chest deformity. Plast Reconstr Surg 1970 0.77
147 Hemispheric laterality and cognitive style associated with transcendental meditation. Psychophysiology 1977 0.76
148 Assessment of new radioimmunoassay kit for determining urinary albumin at low concentrations: comparison with radial immunodiffusion. J Clin Pathol 1986 0.76
149 Prerequisite training in plastic surgery. Plast Reconstr Surg 1990 0.75
150 The management of total xerophthalmia. Trans Am Ophthalmol Soc 1968 0.75
151 Re: Woods et al: lymphoscintigraphy as a guide to treatment in malignant melanoma. Ann Plast Surg 1989 0.75
152 The Devi case and more. Science 1995 0.75
153 Disseminated Nocardia brasiliensis infection. Arch Intern Med 1973 0.75
154 Antigen detection in body fluids of patients with bacterial and fungal infections. Trans Am Clin Climatol Assoc 1983 0.75
155 Nocardiosis of the upper limb. Plast Reconstr Surg 1981 0.75
156 Dosage for malaria treatment. Lancet 1996 0.75
157 The influence of subtumoricidal cobalt 60 irradiation on wound healing and tensile strength. Ann Surg 1970 0.75
158 The management of total xerophthalmia. Arch Ophthalmol 1969 0.75
159 Prolactin levels in hypothyroid and euthyroid infants during the first week of life. Clin Endocrinol (Oxf) 1986 0.75
160 Repair of large myelomeningoceles. Arch Surg 1969 0.75
161 Rapid enzymatic method for measurement of serum flucytosine levels. J Antimicrob Chemother 1986 0.75
162 Reticuloendothelial phagocytic function during systemic mycotic infections in man. J Lab Clin Med 1969 0.75
163 General anesthesia for rhytidectomy. Commentary. Plast Reconstr Surg 1977 0.75
164 Management of a patient after partial chest wall resection and excision of hemidiaphragm. Indiana Med 1984 0.75
165 Cervical thymus gland. Case report. Plast Reconstr Surg 1969 0.75
166 Prevention of nosocomial varicella zoster disease. Ann Intern Med 1981 0.75
167 Resident recruiting, patient care, and problem solving: threats from within. Plast Reconstr Surg 1983 0.75
168 Species identification of invasive aspergillosis in man. Am J Clin Pathol 1972 0.75
169 The treatment of systemic mycoses. Ration Drug Ther 1973 0.75
170 An adjunct to nasolabial flap transfers. Plast Reconstr Surg 1981 0.75
171 An automated diluter suitable for use with the Unicam S.P. 90 Atomic absorption spectrophotometer. J Med Lab Technol 1970 0.75
172 P&T Committee review of fluconazole: an effective alternative to antifungal therapy. Hosp Formul 1990 0.75
173 Skin and soft tissue injuries of the hand in children. Pediatr Clin North Am 1975 0.75
174 Re: Apfelberg et al: a preliminary study of the combined effect of neodymium: YAG laser photocoagulation and direct steroid instillation in the treatment of capillary/cavernous hemangiomas of infancy. Ann Plast Surg 1989 0.75
175 Management of large scalp defects. J Trauma 1970 0.75
176 CMV reactivation in nonmyeloablative HSCT. Bone Marrow Transplant 2001 0.75
177 Reversal of adrenal glucocorticoid dysfunction in a patient with disseminated histoplasmosis. Ann Intern Med 1989 0.75
178 Pharmacological studies with 5-fluorocytosine. Med Radiol (Mosk) 1974 0.75
179 Control of hypercalcemia with cellulose phosphate. J Clin Endocrinol Metab 1968 0.75
180 Harold M. Trusler, M.D. 1897-1972. Plast Reconstr Surg 1973 0.75
181 Ketamine anesthesia in pediatric plastic surgery. Plast Reconstr Surg 1971 0.75
182 The role of aggressive surgical treatment in the severely burned patient. J Trauma 1969 0.75
183 Multilating injuries of the wrist. J Trauma 1971 0.75
184 Paracoccidioidomycosis case report: cure with amphotericin B and triple sulfa. J Med Vet Mycol 1986 0.75
185 Surveillance of nosocomial infections by antibiotic monitoring. JAMA 1979 0.75
186 Single intracavitary insertion and whole pelvis irradiation in treatment of carcinoma of the cervix. J Can Assoc Radiol 1971 0.75
187 Surgical management of soft tissue defects of the ankle-heel region. J Trauma 1972 0.75
188 MMPI correlates of relatively localized brain damage. J Clin Psychol 1984 0.75
189 Letter to the editor: Upper arm tourniquet tolerance in hand surgery. Plast Reconstr Surg 1973 0.75
190 Surgical options in the repair of lower-extremity soft-tissue wounds. J Trauma 1982 0.75
191 Reconstruction of lateral nasal defects. Clin Plast Surg 1981 0.75
192 Achieving economies of scale through shared ancillary and support services. Top Health Care Financ 1981 0.75
193 Functional value analysis: a technique for reducing hospital overhead costs. Top Health Care Financ 1981 0.75
194 Ultrasound evaluation of microanastomosis. Arch Surg 1975 0.75
195 Osteogenic sarcoma of the facial bones. Am J Surg 1968 0.75
196 Cancer of the nose: ablation and repair. Clin Plast Surg 1976 0.75
197 Surgical treatment of skin cancer of the nose. Am J Surg 1969 0.75
198 Initial care of the burned patient. J Indiana State Med Assoc 1980 0.75
199 Graduate education in plastic surgery: time for a change. Plast Reconstr Surg 1985 0.75
200 Excision of giant nevi in children--how should the wound be closed? Ann Plast Surg 1985 0.75
201 Assay of antifungal agent saramycetin (X-5079C) in patient body fluids. Am Rev Respir Dis 1969 0.75
202 Early excision: a financial assessment. J Burn Care Rehabil 1987 0.75
203 Program consolidation and hospital merger: beware the conventional wisdom. Top Health Care Financ 1981 0.75
204 Clinical applications of serologic tests for systemic mycoses. Mod Treat 1970 0.75
205 Grafts and flaps. Plast Reconstr Surg 1989 0.75
206 Functional value analysis: a technique for reducing hospital overhead costs. Top Health Care Financ 1977 0.75
207 Assessing response to therapy for mucosal candidiasis. J Infect Dis 1984 0.75
208 Finger tip avulsions. J Trauma 1966 0.75
209 Chimney sweeper's disease revisited: first case reported in a black. Case report. Plast Reconstr Surg 1978 0.75
210 The prognosis on regionalization is poor. Hosp Trustee 1978 0.75
211 Hand infections. Ohio State Med J 1965 0.75
212 Prevention of hospital-acquired systemic mycoses. Prev Med 1974 0.75
213 Coccidioidomycosis. Report of a case with clinical evidence of ocular involvement. Arch Ophthalmol 1967 0.75
214 Academic plastic surgery--a crisis? Plast Reconstr Surg 1980 0.75
215 The effect of primary wounding on the tensile strength of secondary wounds. Surg Gynecol Obstet 1970 0.75
216 Unsuspected parotid tumors. JAMA 1970 0.75
217 Primary trunk flap coverage of traumatic upper arm defects. J Trauma 1974 0.75
218 Diagnosis and therapy of systemic mycoses in the immunosuppressed host. Transplant Proc 1973 0.75
219 Distal necrosis of dorsal pedicle flaps in the rat: immediate vs delayed terminal inset. Surg Forum 1972 0.75
220 Two views on HDCT-ABMT breast cancer treatment controversy. Too experimental for insurers--or just too expensive? Healthspan 1992 0.75
221 The isolation of red yeast-like fungi in a diagnostic laboratory. J Med Microbiol 1972 0.75
222 Melanoma. J Indiana State Med Assoc 1982 0.75
223 A minor complication of blepharoplasty. Plast Reconstr Surg 1982 0.75
224 Biosafety considerations in handling medically important fungi. Med Mycol 1998 0.75